albiglutide

Home
Ligands
albiglutide

Ligand id: 7386

Name: albiglutide

Classification
Compound class	Peptide or derivative
Approved drug?	Yes (source: FDA and EMA (2014))

International Nonproprietary Names
INN number	INN
8829	albiglutide

Synonyms
Eperzan®
GSK716155
Tanzeum®

Synonyms

Eperzan®

GSK716155

Tanzeum®

Database Links
Specialist databases
IMGT/mAb-DB	397
Other databases
ChEMBL Ligand	CHEMBL2107841
Search PubMed clinical trials	albiglutide
Search PubMed titles	albiglutide
Search PubMed titles/abstracts	albiglutide
Wikipedia	Albiglutide

Comments
Albiglutide is recombinant protein engineered by fusing the gene for glucagon-like peptide 1 (GLP-1; an incretin secreted in the gut) with the gene for human albumin. In this case the GLP-1 appears to contain an amino acid substitution (Ala to Glu at the C-terminal) directly adjacent to the dipeptidyl peptidase-4 (DPP-4; the enzyme responsible for in vivo degradation of GLP-1) hydrolysis site, which renders the peptide resistant to cleavage by this enzyme [3,5]. In conjunction with the fusion to albumin [2] this drug has an extended half-life compared to other approved drug GLP-1 mimetics.

Comments

Albiglutide is recombinant protein engineered by fusing the gene for glucagon-like peptide 1 (GLP-1; an incretin secreted in the gut) with the gene for human albumin. In this case the GLP-1 appears to contain an amino acid substitution (Ala to Glu at the C-terminal) directly adjacent to the dipeptidyl peptidase-4 (DPP-4; the enzyme responsible for in vivo degradation of GLP-1) hydrolysis site, which renders the peptide resistant to cleavage by this enzyme [3,5]. In conjunction with the fusion to albumin [2] this drug has an extended half-life compared to other approved drug GLP-1 mimetics.